Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$1.61M
420K shares
What this filing means
BORGESON BLAKE plans to sell 420K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $1.61M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/7/2026ACC: 0001959173-26-002804
Director
Since Apr 2021
420K
Shares to sell
$1.61M
Approx. market value
30K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
9/19/2017
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/19/2017 | Founders Shares Compensation | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
170K
Market value
$588.2K
3/3/2026
—Completed
Units to sell
220K
Market value
$924.0K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$93.0K
4/7/2026
Total
Units
420K
Value
$1.61M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 170K | $588.2K | — | Completed |
2/3/2026 | 220K | $924.0K | — | Completed |
| Planned — Approximate Date | ||||
4/7/2026 | 30K | $93.0K | NASDAQ | Planned |
| Total | 420K | $1.61M | ||